189 related articles for article (PubMed ID: 29485253)
1. Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.
Fai D; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2019 Oct; 154(5):603-605. PubMed ID: 29485253
[No Abstract] [Full Text] [Related]
2. Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
Neittaanmäki-Perttu N; Grönroos M; Tani T; Snellman E
Acta Derm Venereol; 2016 Jun; 96(5):712-3. PubMed ID: 26806126
[No Abstract] [Full Text] [Related]
3. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
[TBL] [Abstract][Full Text] [Related]
4. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
[No Abstract] [Full Text] [Related]
6. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
7. Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
Bissonnette R; Bolduc C; Maari C; Nigen S
J Am Acad Dermatol; 2012 Dec; 67(6):1386-7. PubMed ID: 23158619
[No Abstract] [Full Text] [Related]
8. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
9. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
10. Daylight photodynamic therapy - Experience and safety in treatment of actinic keratoses of the face and scalp in low latitude and high brightness region.
Galvão LE; Gonçalves HS; Botelho KP; Caldas JC
An Bras Dermatol; 2017; 92(1):142-144. PubMed ID: 28225978
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.
Neittaanmäki-Perttu N; Karppinen TT; Tani T; Snellman E; Grönroos M
Acta Derm Venereol; 2017 Jan; 97(1):120-121. PubMed ID: 27304514
[No Abstract] [Full Text] [Related]
12. Long-term follow-up assessment of daylight photodynamic therapy with methyl aminolevulinate in patients with actinic keratosis.
Fai D; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2017 Jun; 152(3):318-319. PubMed ID: 28409583
[No Abstract] [Full Text] [Related]
13. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
Kellner C; Bauriedl S; Hollstein S; Reinhold U
Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
[No Abstract] [Full Text] [Related]
14. Day light photodynamic therapy with BF-200 ALA: A case series.
Ruiz-Villaverde R; Sáenz-Guirado S; Cuenca-Barrales C; Aguayo-Carreras P
Dermatol Ther; 2018 Sep; 31(5):e12666. PubMed ID: 30198193
[No Abstract] [Full Text] [Related]
15. Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.
Reginato E; Gruber-Wackernagel A; Wolf P
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):274-8. PubMed ID: 25847118
[No Abstract] [Full Text] [Related]
16. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for actinic keratoses: aren't we there yet?
Lui H
JAMA Dermatol; 2014 Dec; 150(12):1289. PubMed ID: 25162746
[No Abstract] [Full Text] [Related]
18. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
Heerfordt IM; Wulf HC
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2058-2061. PubMed ID: 31197894
[TBL] [Abstract][Full Text] [Related]
19. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
Fernández-Guarino M; Harto A; Jaén P
Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686
[TBL] [Abstract][Full Text] [Related]
20. Daylight photodynamic therapy: the Southern California experience.
Lane KL; Hovenic W; Ball K; Zachary CB
Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
